MedTrace Logo

Secondary PRevention in Cardiovascular Disease by a Nursing Guided Program (SPRING)

NCT03234023 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 484

Last updated 2024-12-09

No results posted yet for this study

Summary

DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric.

CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO STUDY: Acute Coronary Syndrome (ACS). INTERVENTION:monitored outhospital not inhospital supervised. MAIN OBJECTIVE: To determine the incidence of major adverse events (total mortality, new ACS, coronary revascularization, all-cause hospitalization) during the one-year period after hospitalization for ACS.

Conditions

  • Acute Coronary Syndrome
  • Nutrition
  • Physical Activity
  • Secondary Prevention

Interventions

BEHAVIORAL

INTERVENTION GROUP

Offer recommendations of healthy living habits and control of pharmacy administration

Sponsors & Collaborators

  • University Hospital A Coruña

    lead OTHER

Principal Investigators

  • Carmen Neri Fernández Pombo, PhD · University Hospital A Coruña

  • Guillermo Aldama López, MD · University Hospital A Coruña

  • José Manuel Vázquez Rodríguez, MD · University Hospital A Coruña

  • Raquel Marzoa Rivas, MD · University Hospital Ferrol

  • Manuel López Pérez, MD · University Hospital Ferrol

  • Marta Lorenzo Carpente, Nurse · University Hospital Ferrol

  • Jose Angel Rodriguez Fernández, MD · University Hospital A Coruña

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2023-02-05
Completion
2023-02-05

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03234023 on ClinicalTrials.gov